Johnson & Johnson Vaccine on Hold

This week, the FDA decided to pause the Johnson & Johnson vaccine following reports that  six women—of the nearly 7 million Americans who have received the J&J vaccine—developed serious blood clots after getting the jab. Is pausing the vaccine worth the tradeoffs? Will the FDA’s move fuel vaccine hesitancy? Sarah, David, Chris and Jonah give us the scoop. Today, our hosts also chat about New York Times columnist Ross Douthat’s latest piece on what Bidenism owes to Trumpism, the GOP’s First Amendment retribution against woke corporations, and what Democratic pollsters have learned from their poor electoral forecasting leading up to the 2020 election.

Show Notes:

Start a Free Trial
Get every newsletter and all of The Dispatch. Support quality, fact-based journalism. Get Started ALREADY HAVE AN ACCOUNT? SIGN IN
Comments (51)
Join The Dispatch to participate in the comments.
Load More